.
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..
�defending the crown� is another way to put it. the king may make mistakes, he may commit heinous offenses, but he is the king, and therefore his position must remain secure..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...
.